Compliance Gap Analysis & Risk Assessment Services

A regulatory compliance gap analysis is a structured review of your current documentation, quality systems, and processes against the exact requirements of a target framework such as FDA, EU MDR, TGA, or ISO 13485. It identifies missing elements, weak evidence, inconsistencies, and high-risk deficiencies, then maps them to specific regulations and provides a prioritized remediation plan.

A compliance risk assessment typically reviews technical documentation, risk management files, clinical evidence, labeling, QMS procedures, post-market processes, and submission readiness. The goal is to determine where regulatory exposure exists, how severe each issue is, and what actions are needed to reduce the likelihood of audit findings, deficiency letters, delayed approvals, or market access interruptions.

These services are valuable for medical device manufacturers, IVD companies, SaMD developers, diagnostic firms, and laboratories preparing for submissions, audits, certifications, or market expansion. They are especially useful for organizations entering a new market, transitioning to updated regulations like EU MDR or IVDR, responding to prior deficiencies, or scaling without a fully built internal RAQA team.

The best time is before a major submission, certification audit, Notified Body review, or market expansion effort. It is also important after significant design changes, quality system updates, acquisitions, remediation projects, or periods of rapid growth. Performing the assessment early helps prevent costly rework, missed timelines, and avoidable regulatory questions later in the process.

An internal audit evaluates whether your organization is following established procedures and meeting applicable quality requirements in practice. A gap analysis goes further by benchmarking your current state against a specific regulatory objective, such as a 510(k), EU MDR submission, or ISO certification. It is more strategic and often focused on readiness, documentation sufficiency, and remediation planning.

A strong compliance assessment should provide a documented findings report, regulatory references for each issue, severity ratings, and a prioritized action plan. Many engagements also include remediation recommendations, ownership guidance, sequencing by risk, and support for closing gaps in technical files, risk management records, labeling, or QMS documentation so teams can move efficiently toward readiness.

Yes. Elexes supports assessments across FDA, EU MDR, TGA, Health Canada, ISO-based quality systems, and other global frameworks. For companies pursuing multiple markets, the team can identify overlapping requirements, market-specific gaps, and documentation alignment issues so your regulatory strategy is coordinated rather than fragmented across separate submissions and compliance efforts.

Timing depends on the device complexity, number of target markets, and condition of your documentation. A focused assessment of a limited scope can move quickly, while broader reviews involving technical files, QMS elements, clinical evidence, and post-market systems take longer. The key factor is depth: the assessment should be thorough enough to produce reliable findings and a realistic remediation roadmap.